Research Article

Metallo-Beta-Lactamase-Producing Acinetobacter spp. from Clinical Isolates at a Tertiary Care Hospital in Ghana

Table 3

Resistant pattern of Acinetobacter isolates.

AntibioticsCDT-veCDT-ve value
ResistantIsolatesIsolates
No. (%)(23) (%)(29) (%)

AMP82 (94.3)23 (100)27 (93.1)0.497
AMC79 (90.8)22 (95.7)27 (93.1)1
AMK22 (25.3)8 (34.8)8 (27.6)0.763
CTX75 (86.2)23 (100)27 (93.1)0.497
CXM79 (90.8)23 (100)27 (93.1)0.497
CAZ66 (75.9)23 (100)29 (100)1
COT61 (70.1)17 (73.9)21 (72.4)1
CIP56 (64.4)20 (87.0)23 (79.3)0.714
GEN63 (72.4)21 (95.7)27 (93.1)0.159
MER52 (59.8)23 (100)29 (100)1
NIT23 (92.0)14 (100)7 (77.8)0.261
LEV59 (67.8)22 (95.7)24 (82.7)0.21

Key: AMP: ampicillin; AMC: amoxicillin-clavulanate; AMK: amikacin; CTX: cefotaxime; CXM: cefuroxime, CAZ: ceftazidime, CIP: ciprofloxacin, COT: cotrimoxazole, GEN: gentamicin, MER: meropenem, NIT: nitrofurantoin, LEV: levofloxacin. CDT-ve: combined disc test negative; CDT+ve: combined disc test positive.